GLIMEPIRIDE+METFORMIN+VOGLIBOSE is a combination of anti-diabetic drugs used to treat type 2 diabetes mellites. Type 2 diabetes is a chronic or lifelong condition that affects the way your body processes glucose. People with type 2 diabetes either do not produce enough insulin or if at all the insulin is produced, it is unable to perform its function in the body (insulin resistance). Due to this, the blood glucose level increases and causes symptoms such as frequent urination, increased thirst and increased hunger start.
GLIMEPIRIDE+METFORMIN+VOGLIBOSE is a combination of three antidiabetic drugs: Glimepiride, Metformin and Voglibose. Glimepiride, which is a 'sulfonylurea', acts by increasing the amount of insulin released by the pancreas. Metformin, which is a 'biguanide', acts by lowering the glucose production in the liver, delaying glucose absorption from the intestines and increasing the body's response to insulin. Voglibose, which is an 'alpha-glucosidase inhibitor', prevents the breakdown of complex sugars into simple sugars such as glucose in the intestine. In a nutshell, the three medicines together prevent the blood glucose levels from rising to very high levels, thus keeping your diabetes under control.
GLIMEPIRIDE+METFORMIN+VOGLIBOSE should be taken with food to avoid an upset stomach. Based on your medical condition, your doctor will decide for how long you need to take GLIMEPIRIDE+METFORMIN+VOGLIBOSE. GLIMEPIRIDE+METFORMIN+VOGLIBOSE may cause certain common side effects such as hypoglycaemia (low blood glucose levels), taste change, nausea, diarrhoea, stomach pain, headache, upper respiratory symptoms. Most of these side effects do not require medical attention and will resolve gradually over time. However, if you experience these side effects persistently, consult your doctor.
Continue taking GLIMEPIRIDE+METFORMIN+VOGLIBOSE for as long as your doctor has advised. If you stop taking GLIMEPIRIDE+METFORMIN+VOGLIBOSE abruptly, it may increase your sugar levels which could further increase the risk of eyesight loss (retinopathy), kidney (nephropathy) and nerve damage (neuropathy). GLIMEPIRIDE+METFORMIN+VOGLIBOSE should not be taken if you have type 1 diabetes mellitus, severe kidney or liver disease. Please inform your doctor if you have any type of heart disease, are planning to get pregnant or are breastfeeding.
Type 2 diabetes mellitus
GLIMEPIRIDE+METFORMIN+VOGLIBOSE contains Glimepiride, Metformin and Voglibose. Glimepiride, which is a 'sulfonylurea', acts by increasing the amount of insulin released by the pancreas. Metformin, which is a 'biguanide', acts by lowering the glucose production in the liver, delaying glucose absorption from the intestines and increasing the body's response to insulin. Voglibose, which is an 'alpha-glucosidase inhibitor' prevents the breakdown of complex sugars into simple sugars such as glucose in the intestine. GLIMEPIRIDE+METFORMIN+VOGLIBOSE prevents the blood glucose levels from rising to very high levels thus keeping your diabetes under control. GLIMEPIRIDE+METFORMIN+VOGLIBOSE also helps to prevent serious complications of diabetes such as kidney damage (Diabetic Nephropathy), blindness (Diabetic Retinopathy), loss of sensation in your hands and feet (Diabetic Neuropathy), GLIMEPIRIDE+METFORMIN+VOGLIBOSE also helps to reduce your chance of having a heart attack or stroke. Being a combination of three drugs, GLIMEPIRIDE+METFORMIN+VOGLIBOSE reduces the need to take multiple pills and hence makes it easier to remember to take the drugs.
Some diabetic patients taking GLIMEPIRIDE+METFORMIN+VOGLIBOSE may develop a rare but serious condition called lactic acidosis. In this condition, there is too much lactic acid accumulated in the blood. So, your liver and kidney proper functioning is required for the elimination of excess lactic acid from the blood. You should not take GLIMEPIRIDE+METFORMIN+VOGLIBOSE if you have kidney disease, as measured by a blood test. GLIMEPIRIDE+METFORMIN+VOGLIBOSE may lower vitamin B12 levels, so try to have blood test annual blood and vitamin. GLIMEPIRIDE+METFORMIN+VOGLIBOSE when used with or without insulin has the tendency to extremely lower the blood sugar level. So, the doctor may lower the dose of insulin. GLIMEPIRIDE+METFORMIN+VOGLIBOSE may lower your thyroid-stimulating hormone (TSH), so an annual check-up of TSH is suggested.
Drug-Drug Interaction: GLIMEPIRIDE+METFORMIN+VOGLIBOSE may interact with insulin, high blood pressure-lowering pills (hydrochlorothiazide, amlodipine), water pills/diuretics (furosemide), heart failure-related medicines (digoxin), anti-hypertensive (metoprolol), steroids (prednisolone), thyroid hormones etc. So, tell your doctor if you are using these drugs before taking GLIMEPIRIDE+METFORMIN+VOGLIBOSE.
Drug-Food Interaction: Taking GLIMEPIRIDE+METFORMIN+VOGLIBOSE with alcoholic beverages may increase the risk of a rare but serious and potentially life-threatening condition known as lactic acidosis (build-up of lactic acid in the blood) and hypoglycaemia.
Drug-Disease Interaction: GLIMEPIRIDE+METFORMIN+VOGLIBOSE should be avoided in patients with vitamin B12 deficiency, kidney problems, liver problems, cardiovascular disease (heart-related issues) and low blood sugar level (hypoglycaemia) as it may worsen the condition.
Taking GLIMEPIRIDE+METFORMIN+VOGLIBOSE with alcohol can cause hypoglycaemia and can also lead to a rare but life-threatening condition known as Lactic Acidosis. So, keep your doctor informed if you drink alcohol.
As the data around the use of GLIMEPIRIDE+METFORMIN+VOGLIBOSE in pregnant women is limited, the use of GLIMEPIRIDE+METFORMIN+VOGLIBOSE in pregnancy is restricted. It is highly recommended to consult your doctor before taking this drug in case you are pregnant.
The name is not recommended during breastfeeding. However, your doctor may prescribe it for you during breastfeeding if he/she feels that the benefit to you outweighs the risk. You should not take GLIMEPIRIDE+METFORMIN+VOGLIBOSE without a doctor's advice.
GLIMEPIRIDE+METFORMIN+VOGLIBOSE may cause hypoglycaemia (low blood sugar levels) whose symptoms include unusual sleepiness, shivering, palpitations, sweating etc. This may affect your ability to drive. Use caution while driving or doing anything that requires concentration.
GLIMEPIRIDE+METFORMIN+VOGLIBOSE to be taken with caution, especially if you have a history of liver diseases/conditions. Dose may have to be adjusted by your doctor depending on your liver function tests.
GLIMEPIRIDE+METFORMIN+VOGLIBOSE to be taken with caution, especially if you have a history of Kidney diseases/conditions. Dose may have to be adjusted by your doctor depending on your kidney function tests.
GLIMEPIRIDE+METFORMIN+VOGLIBOSE is not recommended for children below the age of 18 years. The safety and effectiveness of GLIMEPIRIDE+METFORMIN+VOGLIBOSE has not been established in children due to limited evidence. So, only take GLIMEPIRIDE+METFORMIN+VOGLIBOSE if the doctor has prescribed GLIMEPIRIDE+METFORMIN+VOGLIBOSE.
Diabetes Mellitus type 2 is a condition in which either the body stops producing enough insulin (the hormone which helps to decrease sugar levels in the blood) or there is resistance to the action of insulin. As a result, excessive insulin is produced but it fails to act on the organs of the body. Symptoms of type 2 diabetes include feeling exhausted all time, feeling thirsty, having blurry vision, and urge to urinate (pee) more often. Complications of type 2 diabetes include skin infection, eye problems (retinopathy), nerve damage (neuropathy), diabetic foot (foot ulcer), kidney disease (nephropathy), high blood pressure and even stroke.
Glycomet Trio 2 Tablet 10's
₹191.7 (MRP 225.5)15%Off
Glimisave MV 3.3 Tablet 10's
₹140.4 (MRP 159.5)12%Off
Amaryl MV Tablet 15's
₹206.4 (MRP 234.5)12%Off
Trivolib Forte 2Mg Tab 15'S
₹207.2 (MRP 235.5)12%Off